This is the authors' abstract. We don't add key points for this paper.
Despite years of research, the five-year survival rate among patients with lung cancer is a mere 14 percent. Lung cancer is divided into two major types — non–small-cell lung cancer and the more aggressive small-cell lung cancer. This review considers the treatment of each type in the framework of multidisciplinary management and recent clinical trials.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Spira et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: